Residue-Specific Impact of EDTA and Methionine on Protein Oxidation in Biotherapeutics Formulations Using an Integrated Biotherapeutics Drug Product Development Workflow-Reference-Cited by-同舟云学术

Residue-Specific Impact of EDTA and Methionine on Protein Oxidation in Biotherapeutics Formulations Using an Integrated Biotherapeutics Drug Product Development Workflow

Published:2023-02 Issue:2 Volume:112 Page:471-481
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Thakkar Santosh V.^ORCID,Rodrigues Danika,Zhai Bo,Banton Dwaine,Somani Sandeep^ORCID,Javidi Alex,Mahan Andrew,Ember Stuart,DeGrazio Dominick,Ganguly Subinay,Amin Ketan,Nanda Hirsh

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. The Molecular Interaction Process;Laue;J Pharm Sci,2020

2. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies;Thakkar;J Pharm Sci,2012

3. Protein aggregation and its inhibition in biopharmaceutics;Wang;Int J Pharm,2005

4. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics;Singh;J Pharm Sci,2010

5. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality;Carpenter;J Pharm Sci,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability of Protein Pharmaceuticals: Recent Advances;Pharmaceutical Research;2024-06-27

2. Development of a high throughput oxidation profiling strategy for monoclonal antibody products;European Journal of Pharmaceutics and Biopharmaceutics;2024-06

3. Vaporized Hydrogen Peroxide Sterilization in the Production of Protein Therapeutics: Uptake and Effects on Product Quality;Journal of Pharmaceutical Sciences;2023-12